The molecular basis of quantitative fibrinogen disorders.
about
Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding DisordersThe natural occurrence of human fibrinogen variants disrupting inter-chain disulfide bonds (A{alpha}Cys36Gly, A{alpha}Cys36Arg and A{alpha}Cys45Tyr) confirms the role of N-terminal A{alpha} disulfide bonds in protein assembly and secretionMassive hemoperitoneum due to a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemiaThree cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.Treatment of congenital fibrinogen deficiency: overview and recent findings.Fibrinogen as a key regulator of inflammation in disease.Blood component support in acquired coagulopathic conditions: is there a method to the madness?Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management.Fibrin Formation, Structure and Properties.Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.Dysfibrinogenemia with Subgaleal Hematoma: An Unusual Presentation.Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.Molecular basis of quantitative fibrinogen disorders in 27 patients from India.Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains.Successful living-related kidney transplantation in a boy with inherited dysfibrinogenemia.A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion.A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution.Clauss assay and fibrinogen protein estimated by capillary zone electrophoresis.Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans.Molecular analysis of afibrinogenemic mutations caused by a homozygous FGA1238 bp deletion, and a compound heterozygous FGA1238 bp deletion and novel FGA c.54+3A>C substitution.Effects of preoperative plasma exchange therapy with albumin replacement fluid on blood coagulation in patients undergoing ABO-incompatible living-donor kidney transplantation using rotational thromboelastometry.
P2860
Q33608224-41B14435-A918-4F91-A935-BA44EF98022EQ35143518-4C4AF23C-A08F-4569-9A5A-32142412DFE3Q36107624-3F48389B-43BB-4C38-96A6-B295D60B7DD4Q36148140-5132EFBA-96FD-436C-8017-6EAF6A597B80Q37119660-6CADFB86-D558-4555-8F60-210722799D22Q37388583-EAC307BF-A749-4512-A9D3-8C6013DEDEB7Q37950860-7EF39DF1-4A58-407E-AA9D-1812E73385BDQ37999723-D5D0DEFD-9296-4595-BDC6-508ED6B0FAE9Q38862618-1ED680B1-4B3C-427E-8AB5-FB7532E37210Q39013217-9DC3A218-9C31-4E1F-A819-4881C817D6C5Q40873470-CFEA7C4D-4D86-4DF4-96E2-BA94D99FE42BQ41282193-3FF49450-B5BB-400F-928A-48A718927E5FQ42210164-3E31D722-3E0E-481A-A529-DAEDDA5EF654Q45876607-B262A31A-53A4-43B8-BD95-78491B93D07AQ45886377-8DE2DA95-4EC3-4B60-A877-9609FB69EB76Q46630483-9F887BF9-44B1-4440-829A-E13097A97447Q46642619-F14CB87D-AFCA-45C8-B19D-7064152B3049Q47201972-D2CE4A8B-8A29-422B-B500-9EDBCD61CFEDQ47922026-5893C810-6DC6-4E40-907F-BEA6C63638BAQ49495916-39E3ADDF-2A30-4746-8F3F-4B523AE4E67FQ49498930-61ECDABA-ABAF-45AB-ADB4-E4EA9B996D67Q50597437-B3953312-0F71-4269-AF5A-7DD0193A83E6Q50715392-DB13081F-82F9-4EE2-B9E7-652E0CB70ADFQ51059920-8B5AAD5D-8E58-4F30-9FDC-F3CD9FAE7AF5Q51322573-C658DBE7-8330-4033-BC6A-CA7CB51D79D6Q51758787-0ACAA763-84CD-46FA-AD74-5E9DED795748Q55394946-8DB81D9F-6B36-4BBA-B48D-3D0D622F1E2A
P2860
The molecular basis of quantitative fibrinogen disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The molecular basis of quantitative fibrinogen disorders.
@ast
The molecular basis of quantitative fibrinogen disorders.
@en
type
label
The molecular basis of quantitative fibrinogen disorders.
@ast
The molecular basis of quantitative fibrinogen disorders.
@en
prefLabel
The molecular basis of quantitative fibrinogen disorders.
@ast
The molecular basis of quantitative fibrinogen disorders.
@en
P2860
P1476
The molecular basis of quantitative fibrinogen disorders
@en
P2093
Tenchini ML
P2860
P304
P356
10.1111/J.1538-7836.2006.02094.X
P577
2006-10-01T00:00:00Z